如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: 松弛肽(RLN)單克隆抗體
產(chǎn)品型號(hào): RLN
產(chǎn)品展商: HZbscience
產(chǎn)品文檔: 無相關(guān)文檔
簡(jiǎn)單介紹
松弛肽(RLN)單克隆抗體是針對(duì)RLN的小鼠單克隆抗體。在**組織化學(xué)染色和**印跡實(shí)驗(yàn)中能識(shí)別RLN。松弛肽(RLN)單克隆抗體主要用于WB; ICC; IHC-P; IHC-F; ELISA; IP; IF; FCM等多種**學(xué)實(shí)驗(yàn)，一抗，二抗，標(biāo)簽抗體，內(nèi)參抗體、信號(hào)通路抗體、細(xì)胞凋亡抗體等現(xiàn)貨供應(yīng)，獲得高靈敏度和高特異性的一致性結(jié)果的不二之選，產(chǎn)品靈敏度高，可重現(xiàn)性好，相同的名稱，不同的物種，多種規(guī)格供應(yīng),售后完善。
松弛肽(RLN)單克隆抗體
的詳細(xì)介紹
松弛肽(RLN)單克隆抗體
-
來源單抗制備
-
宿主小鼠
-
效價(jià)(克隆號(hào))-
-
Ig亞型IgG
-
純化方式抗原特異性親和純化
-
松弛肽(RLN)單克隆抗體標(biāo)記物無標(biāo)記物
-
**原-
-
緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
-
性狀液體
-
濃度500ug/ml
-
且適物種-
-
應(yīng)用WB, ICC, IHC-P, IHC-F, ELISA
-
松弛肽(RLN)單克隆抗體Monoclonal Antibody to Relaxin (RLN)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
9th Edition (Revised in Jul, 2013)
[ PRODUCT INFORMATION ]
Immunogen: RLN-OVA
Clonality: Monoclonal
Clone number: A6
Host: Mouse
Immunoglobulin Type: IgG1 Kappa
Purification: Affinity Chromatography.
Applications: WB, ICC, IHC-P, IHC-F, ELISA
Concentration: 500μg/mL
UOM: 200μg
松弛肽(RLN)單克隆抗體[ IMMUNOGEN INFORMATION ]
Immunogen: Synthetic Peptide, RLN conjugated to OVA.
Accession No.: CPB216Hu21
[ ANTIBODY SPECIFITY ]
The antibody is a mouse monoclonal antibody raised against RLN. It has been
selected for its ability to recognize RLN in immunohistochemical staining and
western blotting.
[ APPLICATIONS ]
Western blotting: 1:100-400
Immunocytochemistry in formalin fixed cells: 1:100-500
Immunohistochemistry in formalin fixed frozen section: 1:100-500
Immunohistochemistry in paraffin section: 1:50-200
Enzyme-linked Immunosorbent Assay: 1:100-200
Optimal working dilutions must be determined by end user.
[ CONTENTS ]
Form & Buffer: Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
松弛肽(RLN)單克隆抗體[ STORAGE ]
Store at 4
oC for frequent use. Stored at -20oC to -80
oC in a manual defrost freezer
for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
